Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.630
+0.050 (3.16%)
Mar 4, 2026, 4:00 PM EST - Market closed
Innate Pharma Employees
Innate Pharma had 174 employees as of June 30, 2025. The number of employees decreased by 7 or -3.87% since the number was reported on December 31, 2024.
Employees
174
Change
-7
Growth
-3.87%
Revenue / Employee
$85,286
Profits / Employee
-$310,817
Market Cap
152.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sangamo Therapeutics | 183 |
| Zentalis Pharmaceuticals | 166 |
| Rani Therapeutics Holdings | 106 |
| Immunic | 90 |
| Connect Biopharma Holdings | 62 |
| Milestone Pharmaceuticals | 33 |
| Corbus Pharmaceuticals Holdings | 28 |
| Black Diamond Therapeutics | 24 |
IPHA News
- 14 days ago - Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Finanz Nachrichten
- 14 days ago - Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Business Wire
- 14 days ago - Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Wallstreet:Online
- 15 days ago - Innate Pharma SA: Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference - Finanz Nachrichten
- 15 days ago - Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025 - Business Wire
- 2 months ago - Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 - Business Wire
- 3 months ago - Innate Pharma Releases Its 2026 Financial Calendar - Business Wire